TONIX PHARMACEUTICALS HOLDIN (TNXP) Institutional Ownership and Insiders Activity
TONIX PHARMACEUTICALS HOLDIN (TNXP) is widely held by institutional investors, with 102 firms reporting positions valued at approximately $117.10M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $17.84M in TNXP holdings in its latest filing.
Institutional Holders
102
Total Reported Value
$117.10M
Largest Holder
Blackrock, Inc.
Largest Position
$17.84M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
28
Funds Exiting Positions
9
Top Institutional Owners
View allInvestorReported Balance
- Blackrock, Inc.$17.84M
- Point72 Asset Management, L.P.$14.89M
- Millennium Management Llc$12.34M
- Aqr Capital Management Llc$11.26M
- Vanguard Capital Management Llc$8.83M
Related TNXP Institutional Insights:
- TNXP 13F Institutional Holders
- TNXP Superinvestors
- TNXP Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TNXP Insider Trading & SEC Form 4 Activity
- TNXP Articles
- Top Institutional Investor Stock Rankings